TRUPHARMA, LLC

Trupharma LLC specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in producing drugs, hematological agents, and related therapeutics for federal healthcare delivery systems. The company operates within the strict regulatory framework governing pharmaceutical quality, cGMP compliance, and controlled substance handling, ensuring consistent production of mission-critical medications. Their technical capabilities include formulation development, sterile and non-sterile manufacturing processes, batch record control, and supply chain integrity for pharmaceutical products used in clinical and institutional settings. While limited public performance data is available, their award under the Federal Supply Schedule suggests established proficiency in meeting VA’s stringent procurement standards for pharmaceuticals, including packaging, labeling, and just-in-time logistics for nationwide distribution. Trupharma’s primary agency engagement is with the Department of Veterans Affairs, where they supply pharmaceuticals under the Federal Supply Schedule, indicating a focused relationship centered on fulfilling VA’s chronic care, specialty pharmacy, and inpatient medication needs. Their work supports veteran healthcare delivery through reliable, FDA-compliant drug procurement channels, suggesting a track record of meeting VA’s unique formulary and distribution requirements. The company’s core industry focus is pharmaceutical preparation manufacturing (NAICS 325412), placing them squarely in the niche of active pharmaceutical ingredient processing, tablet and capsule production, and liquid formulation manufacturing. They serve the government healthcare market by providing essential medications that support outpatient, long-term, and acute care regimens, positioning them as a specialized supplier within the federal pharmaceutical supply chain. Trupharma LLC is a small business entity structured as a 2K concern, headquartered in Tampa, Florida. The company holds no formal government certifications such as 8(a), HUBZone, or WOSB, and operates without third-party accreditations publicly disclosed. Their geographic presence is centered in Florida, with federal market positioning rooted in direct pharmaceutical supply to VA and potentially other defense and civilian health agencies requiring compliant drug manufacturing capabilities.